Canwei Wang
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Medicine top 10%
- Curcumin's Biomedical Applications
Papers in
-
- Kruppel-like factors research 1
- Fibroblast Growth Factor Research 1
-
- Bioactive Compounds and Antitumor Agents 3
- Co-authors
- Ri Cui (4 shared papers)Guang Liang (3 shared papers)Xiangjie Huang (3 shared papers)Changtian Yin (2 shared papers)Peng Zou (2 shared papers)Wangyu Zhu (2 shared papers)Chengguang Zhao (1 shared paper)Xiaokun Li (1 shared paper)
- Journals
- Journal of Cellular and Molecular Medicine (2 papers)Phytomedicine (1 paper)Frontiers in Pharmacology (1 paper)Proceedings of the National Academy of Sciences (1 paper)Journal of Experimental & Clinical Cancer Research (1 paper)
- Partner nations
- ChinaItalyUnited States
In The Last Decade
Canwei Wang
6 papers receiving 333 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 142
- Molecular Medicine 35
- Molecular Biology 254
- Toxicology 9
- Cell Biology 30
Countries citing papers authored by Canwei Wang
This map shows the geographic impact of Canwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canwei Wang more than expected).
Fields of papers citing papers by Canwei Wang
This network shows the impact of papers produced by Canwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canwei Wang. The network helps show where Canwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Canwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 135 | |
| 2 | 2019 | 111 | |
| 3 | 2019 | 32 | |
| 4 | 2022 | 25 | |
| 5 | 2020 | 18 | |
| 6 | 2021 | 13 |
About Canwei Wang
Canwei Wang is a scholar working on Molecular Biology, Toxicology, Oncology, Organic Chemistry and Rheumatology, having authored 6 papers that have together received 334 indexed citations. Recurring topics across this work include Bioactive Compounds and Antitumor Agents (3 papers), Kruppel-like factors research (1 paper), Cytokine Signaling Pathways and Interactions (1 paper), Quinazolinone synthesis and applications (1 paper), Hippo pathway signaling and YAP/TAZ (1 paper), MicroRNA in disease regulation (1 paper), Cancer-related Molecular Pathways (1 paper) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Cancer Research (142 citations), Molecular Medicine (35 citations), Molecular Biology (254 citations), Toxicology (9 citations) and Cell Biology (30 citations). Canwei Wang has collaborated with scholars based in China, Italy and United States. Frequent co-authors include Ri Cui, Guang Liang, Xiangjie Huang, Changtian Yin, Peng Zou, Wangyu Zhu, Chengguang Zhao, Xiaokun Li, Carlo M. Croce and Yumin Wang. Their work appears in journals such as Journal of Cellular and Molecular Medicine, Phytomedicine, Frontiers in Pharmacology, Proceedings of the National Academy of Sciences and Journal of Experimental & Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.